Literature DB >> 8175700

Structure and inducible regulation of the human MET promoter.

G Gambarotta1, S Pistoi, S Giordano, P M Comoglio, C Santoro.   

Abstract

The MET oncogene, encoding the tyrosine kinase receptor for the hepatocyte growth factor/scatter factor, is expressed in epithelial cells and overexpressed in a significant proportion of human epithelial cancers, suggesting the occurrence of transcriptional alteration(s). To identify the MET promoter, we isolated recombinant cDNA clones encompassing the entire 5'-noncoding sequence of MET messenger RNAs. Using probes derived from this region, we cloned the entire genomic region spanning the first MET exon and the flanking regulatory sequences. The first exon, containing the entire untranslated sequence, is present in the MET mRNAs of 7.1, 5.9, and 4.6 kilobases, showing that the expression of the multiple transcripts is regulated by a single promoter. The start site of transcription was determined by primer extension and by rapid amplification of cDNA ends. We show that a 300-base pair fragment, containing sequences upstream from the start site, efficiently drives the expression of a reporter gene in transfected epithelial cells. This promoter fragment also contains the cis-acting elements responsible for phorbol-ester induction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175700

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Negative feedback regulation of Met-dependent invasive growth by Notch.

Authors:  M Cristina Stella; Livio Trusolino; Selma Pennacchietti; Paolo M Comoglio
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 2.  Hepatocyte growth factor/scatter factor-induced intracellular signalling.

Authors:  K A Stuart; S M Riordan; S Lidder; L Crostella; R Williams; G G Skouteris
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

3.  Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.

Authors:  Elisa Vigna; Cristina Chiriaco; Simona Cignetto; Lara Fontani; Cristina Basilico; Fiorella Petronzelli; Paolo M Comoglio
Journal:  Mol Oncol       Date:  2015-06-05       Impact factor: 6.603

4.  Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion.

Authors:  S Empereur; S Djelloul; Y Di Gioia; E Bruyneel; M Mareel; J Van Hengel; F Van Roy; P Comoglio; S Courtneidge; C Paraskeva; E Chastre; C Gespach
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling.

Authors:  Bo Cen; Ying Xiong; Jin H Song; Sandeep Mahajan; Rachel DuPont; Kristen McEachern; Daniel J DeAngelo; Jorge E Cortes; Mark D Minden; Allen Ebens; Alice Mims; Amanda C LaRue; Andrew S Kraft
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

6.  Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1.

Authors:  Bo Cen; Sandeep Mahajan; Wenxue Wang; Andrew S Kraft
Journal:  Cancer Res       Date:  2013-04-12       Impact factor: 12.701

7.  The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival.

Authors:  James Y Dai; Marie C DeFrances; Chunbin Zou; Carla J Johnson; Reza Zarnegar
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

8.  PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene.

Authors:  Joseph B Mascarenhas; Kacey P Young; Erica L Littlejohn; Brian K Yoo; Ravi Salgia; Deborah Lang
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

9.  Pax3 modulates expression of the c-Met receptor during limb muscle development.

Authors:  J A Epstein; D N Shapiro; J Cheng; P Y Lam; R L Maas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors.

Authors:  F Galimi; G P Bagnara; L Bonsi; E Cottone; A Follenzi; A Simeone; P M Comoglio
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.